Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo khoa học: " Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: " Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study. | Radiation Oncology BioMed Central Open Access Hypofractionated intensity modulated irradiation for localized prostate cancer results from a phase I II feasibility study Sara Junius1 Karin Haustermans 1 Barbara Bussels2 Raymond Oyen3 Bianca Vanstraelen4 Tom Depuydt4 Jan Verstraete4 Steven Joniau5 and Hendrik Van Poppel5 Address 1Radiation Oncology University Hospital Gasthuisberg Herestraat 49 3000 Leuven Belgium 2Radiation Oncology H. Hartziekenhuis Wilgenstraat 2 8800 Roeselare Belgium 3Radiology University Hospital Gasthuisberg Herestraat 49 3000 Leuven Belgium 4Physics University Hospital Gasthuisberg Herestraat 49 3000 Leuven Belgium and 5Urology University Hospital Gasthuisberg Herestraat 49 3000 Leuven Belgium Email Sara Junius - sara.junius@uz.kuleuven.ac.be Karin Haustermans - karin.haustermans@uz.kuleuven.ac.be Barbara Bussels - Bbussels@hhr.be Raymond Oyen - raymond.oyen@uz.kuleuven.ac.be Bianca Vanstraelen - bianca.vanstraelen@uz.kuleuven.ac.be Tom Depuydt - tom.depuydt@uz.kuleuven.ac.be Jan Verstraete - jan.verstraete@uz.kuleuven.ac.be Steven Joniau - steven.joniau@uz.kuleuven.ac.be Hendrik Van Poppel - hendrik.vanpoppel@uz.kuleuven.ac.be Corresponding author Published 8 August 2007 Received 14 May 2007 Radiation Oncology 2007 2 29 doi 10.1186 1748-717X-2-29 Accepted 8 August 2007 This article is available from http www.ro-journal.cOm content 2 1 29 2007 Junius et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background To assess acute primary endpoint and late toxicity quality of life QOL biochemical or clinical failure secondary endpoints of a hypofractionated IMRT schedule for prostate cancer PC . Methods 38 men with localized PC received 66 Gy 2.64 Gy to prostate 2 Gy to seminal vesicles 50 Gy